LONDON, February 11, 2013 /PRNewswire/ --
Growing life expectancy is a good indicator of a nation's economic status, but at the very same time it also brings about the higher incidences of diseases and ailments. While the picture does not look pretty in general, it certainly is an attractive one for drug store companies. With growing demand for drugs, companies like GNC Holdings Inc. (NYSE: GNC) and Walgreen Co. (NYSE: WAG) are all set to see their stock prices soaring. These companies are also looking to expand their reach internationally. The sector also features competition, but the pie is big enough for all the players involved. StockCall has posted free technical research on GNC Holdings and Walgreen which can be downloaded upon sign up at http://www.stockcall.com/signup
GNC Holdings Continues on Growth Trajectory
GNC Holdings Inc. stock grew by 25 percent in the past 12 months and is rightly being lapped up by hedge funds. As per a recent filing by Citadel Investments, billionaire investor Ken Griffin now owns 3.5 million shares of the company, which is almost the double of its initial investment in the company. Alexander Mitchell's Scopus Asset Management also owns 2.5 million shares of the company. Hedge fund interest generally bodes well for a stock. The company holds leading position in nutrition and vitamins market. Sign up and read the complimentary report on GNC Holdings at http://www.StockCall.com/GNC021113.pdf
Apart from hedge fund interest, the company is doing well. GNC Holdings management upped its guidance for FY 2013. It is experiencing all-round growth as all its major seg
Copyright©2012 PR Newswire.
All rights reserved